Star Scientific, Inc. (Nasdaq: CIGX) announced that on Friday, February19 the company filed an application with the Food & Drug Administration forapproval to market Ariva-BDL(TM) as a "modified risk" tobacco product underthe Family Smoking Prevention and Tobacco Control Act of 2009.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.